Q3 2023 Holdings
Filed 2023-11-13 | 26 holdings | $299.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-12-12) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alpine Immune Sciences, Inc.(NVLSEUR)A | COM | 02083G100 | $76.8M | 6,708,288 | 25.6% |
| Alpine Immune Sciences, Inc. | COM | 010392595 | $76.8M | 6,708,288 | 24.5% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $42.1M | 2,099,583 | 14.1% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $18.2M | 1,163,123 | 6.1% |
| Roivant Sciences LTD | COM | 00BMW4NZ9 | $17.0M | 1,459,700 | 5.4% |
| Roivant Sciences LTD(ROIV)A | COM | G76279101 | $17.0M | 1,459,700 | 5.7% |
| Acelyrin Inc(nsm) | COM | 00445A100 | $15.7M | 1,548,317 | 5.3% |
| Arcus Biosciences, Inc(RCUS) | COM | 03969F109 | $15.6M | 869,790 | 5.2% |
| 10x Genomics, Inc.(TXG) | CL A COM | 88025U109 | $14.8M | 359,554 | 4.9% |
| Argenx SE(ARGX) | SHS | 04016X101 | $13.5M | 27,429 | 4.5% |
| Everest Medicines Limited(NBP) | COM | 44975P103 | $13.3M | 4,166,667 | 4.3% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $12.2M | 1,463,872 | 4.1% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $11.1M | 80,859 | 3.7% |
| Lantheus Holdings Inc(nms)(LNTH) | COM | 516544103 | $9.9M | 142,196 | 3.3% |
| Horizon Therapeutics PLC | COM | G46188101 | $9.1M | 78,900 | 3.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $8.8M | 850,000 | 2.9% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $6.6M | 415,880 | 2.2% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $4.9M | 23,014 | 1.6% |
| Cue Health Inc.(HLTHQ) | COM | 229790100 | $4.0M | 8,980,909 | 1.3% |
| BeyondSpring Inc. | SHS | 00BD36JB9 | $4.0M | 4,958,143 | 1.3% |
| BeyondSpring Inc.(BYSI)A | SHS | G10830100 | $4.0M | 4,958,143 | 1.3% |
| Terns Pharmaceuticals, Inc.(TERN) | COM | 880881107 | $3.6M | 714,285 | 1.2% |
| Equillium Inc.(EQ) | COM | 29446K106 | $3.3M | 4,447,308 | 1.1% |
| Aadi Bioscience, Inc.(WHWK) | COM | 00032Q104 | $2.5M | 526,329 | 0.9% |
| AtriCure Inc. | COM | 004963C20 | $2.0M | 46,259 | 0.6% |
| AtriCure Inc.(ATRC)A | COM | 04963C209 | $2.0M | 46,259 | 0.7% |
| Scynexis Inc.(SCYX) | COM NEW | 811292200 | $1.3M | 555,555 | 0.4% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $1.1M | 904,268 | 0.4% |
| Pyxis Oncology, Inc (formerly Apexigen) | COM | 03759B102 | $650.4K | 326,810 | 0.2% |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS)A | COM | 747324101 | $650.4K | 326,810 | 0.2% |
| GeneDx Holdings Corp.(SMFRUSD) | COM CL A | 81663L101 | $377.1K | 103,604 | 0.1% |
| GeneDx Holdings Corp.(WGS)A | COM CL A | 81663L200 | $377.1K | 103,604 | 0.1% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $274.3K | 200,201 | 0.1% |